Cribstone Capital Management buys $1,626,216 stake in McKesson Corporation (MCK)

McKesson Corporation (MCK) : Cribstone Capital Management scooped up 778 additional shares in McKesson Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 18, 2016. The investment management firm now holds a total of 8,195 shares of McKesson Corporation which is valued at $1,626,216.McKesson Corporation makes up approximately 1.01% of Cribstone Capital Management’s portfolio.

Other Hedge Funds, Including , Fox Run Management L.l.c. sold out all of its stake in MCK during the most recent quarter. The investment firm sold 2,100 shares of MCK which is valued $416,724.Douglass Winthrop Advisors reduced its stake in MCK by selling 2,659 shares or 43.16% in the most recent quarter. The Hedge Fund company now holds 3,502 shares of MCK which is valued at $691,330. McKesson Corporation makes up approx 0.05% of Douglass Winthrop Advisors’s portfolio.Gofen Glossberg Il boosted its stake in MCK in the latest quarter, The investment management firm added 170 additional shares and now holds a total of 2,280 shares of McKesson Corporation which is valued at $450,095. McKesson Corporation makes up approx 0.02% of Gofen Glossberg Il’s portfolio.Osborn Rohs Williams Donohoe Ltd reduced its stake in MCK by selling 149 shares or 0.96% in the most recent quarter. The Hedge Fund company now holds 15,338 shares of MCK which is valued at $2,957,013. McKesson Corporation makes up approx 0.57% of Osborn Rohs Williams Donohoe Ltd’s portfolio.

McKesson Corporation opened for trading at $198.04 and hit $199.27 on the upside on Wednesday, eventually ending the session at $198.44, with a gain of 0.24% or 0.47 points. The heightened volatility saw the trading volume jump to 8,87,048 shares. Company has a market cap of $44,653 M.

On the company’s financial health, McKesson Corporation reported $2.44 EPS for the quarter, missing the analyst consensus estimate by $ -0.70 based on the information available during the earnings call on May 4, 2016. Analyst had a consensus of $3.14. The company had revenue of $46678.00 million for the quarter, compared to analysts expectations of $46810.61 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.94 EPS.

Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016. McKesson Corporation was Downgraded by Avondale to ” Mkt Perform” on May 5, 2016.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Leave a Reply

McKesson Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on McKesson Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.